| Value | ₹0.09 Cr |
|---|
BSE filing, NSE: RGL. Summary written from the filing by ALFA Finder's alert engine.
Renaissance Global Ltd: key numbers
- Share price
- ₹141.11
- Market cap
- ₹1,516 Cr
- Revenue (annual)
- ₹2,813 Cr
- Net profit (annual)
- ₹90.09 Cr
- P/E (TTM)
- 13.9×Sector 49.0×
- Promoter holding
- 61.93%-0.02% QoQ
- FII holding
- 3.96%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Renaissance Global Ltd
All →Renaissance Global Other Announcement
Renaissance Global Limited has appointed Cygnus Partners Private Limited as its Investor Relations Agency. This is a routine administrative appointment for advisory services.
Renaissance Global Employee Stock Options
Renaissance Global allotted 40,000 equity shares under the RGL ESOP 2021 scheme following the exercise of options by employees.
Renaissance Global Business Update
Renaissance Global Ltd has terminated its Investor Relations Agency Agreement with Merlin Capital Advisors by mutual consent, effective October 13, 2026.
Renaissance Global Other Announcement
Renaissance Global received a voluntary ESG rating of '65 Strong' from CRISIL ESG for FY 2025-26. The company was not engaged for the rating; it was assigned independently from public data.
Renaissance Global Promoter Reclassification
BSE and NSE rejected Renaissance Global Limited's application to reclassify Mr. Amit Shah from 'Promoter' to 'Public' category, citing non-compliance with regulatory control and shareholding conditions.
Renaissance Global Employee Stock Options
Renaissance Global Limited allotted 3,750 equity shares upon exercise of ESOPs. The exercise generated proceeds of ₹0.04 Crore for the company.
- Value
- ₹0.04 Cr
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.